Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
adults (culture results pending)
empirical intravenous antibiotics
All adults should initially receive empirical intravenous antibiotics based on local microbiology guidelines to cover the likely causative organisms, both aerobic and anaerobic. Clinicians should keep in mind differences between community-acquired and hospital-acquired pathogens. Once culture results from the pleural fluid are obtained, antibiotics may be tailored to the sensitivities of the grown culture.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
For patients with community-acquired empyemas in whom the risk for methicillin-resistant Staphylococcus aureusand highly resistant gram-negative infection is low, the recommended treatment is with a second- or third-generation cephalosporin (e.g., cefuroxime, ceftriaxone) or an aminopenicillin with a beta-lactamase inhibitor (e.g., amoxicillin/clavulanate). However, due to emerging resistance patterns, clinicians should familiarise themselves with a local antibiogram. Amoxicillin/clavulanate is active against a range of anaerobes, but ceftriaxone requires the addition of an antibiotic with anaerobic cover, such as metronidazole. Clindamycin may be used as an alternative to metronidazole.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
In general, empirical antibiotics with activity against atypical organisms are not necessary.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
Primary options
cefuroxime: 750-1500 mg intravenously every 6-8 hours
or
ceftriaxone: 1-2 g intravenously every 12-24 hours
-- AND --
metronidazole: 15 mg/kg intravenously as a loading dose, followed by 7.5 mg/kg every 6 hours, maximum 4000 mg/day
or
clindamycin: 600 mg intravenously every 6-12 hours; or 900 mg intravenously every 8-12 hours
OR
amoxicillin/clavulanate: 1.2 g intravenously every 8 hours
More amoxicillin/clavulanateDose consists of 1 g amoxicillin plus 0.2 g clavulanate.
chest tube drainage
Treatment recommended for ALL patients in selected patient group
Urgent chest drain insertion is essential in all adults with empyema or complicated parapneumonic effusion.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
How to insert an intercostal (chest) drain using the Seldinger technique. Video demonstrates: how to identify a safe site for insertion; use of an introducer needle, guidewire, dilators, and intercostal drain; how to confirm drain position; and post-procedure care.
Chest drains should be inserted by competent personnel under imaging (ultrasound) guidance to reduce the risk of complications that include organ damage, haemorrhage, subcutaneous emphysema, and death.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com [40]Kesieme EB, Dongo A, Ezemba N, et al. Tube thoracostomy: complications and its management. Pulm Med. 2012;2012:256878. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195434 http://www.ncbi.nlm.nih.gov/pubmed/22028963?tool=bestpractice.com
There is no consensus on the optimal chest tube size for drainage, although it is likely that small-bore chest drains (10-14F) are as effective as large-bore drains (20-28F).[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com [41]Tattersall DJ, Traill ZC, Gleeson FV. Chest drains: does size matter? Clin Radiol. 2000 Jun;55(6):415-21. http://www.ncbi.nlm.nih.gov/pubmed/10873685?tool=bestpractice.com Small-bore drains have also been shown to be less painful for patients.[42]Hallifax RJ, Psallidas I, Rahman NM. Chest drain size: the debate continues. Curr Pulmonol Rep. 2017;6(1):26-9. https://link.springer.com/article/10.1007/s13665-017-0162-3 http://www.ncbi.nlm.nih.gov/pubmed/28344925?tool=bestpractice.com Regular flushing with saline is recommended for small-bore chest drains and if the chest drain becomes blocked.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
The chest drain should remain in place until the effusion has resolved and drainage has stopped.
supportive care
Treatment recommended for ALL patients in selected patient group
Antipyretics and analgesics should be administered as indicated. The authors make no recommendations for specific antipyretics and analgesics. Agents should be used in accordance with local protocols.
Good nursing care, ensuring maintenance of appropriate dietary intake with nutritional supplements if necessary, is paramount. Early mobilisation is also essential.
fluid resuscitation
Additional treatment recommended for SOME patients in selected patient group
Patients may be septic at presentation and require emergency fluid resuscitation and urgent intravenous antibiotics even before the diagnosis is established.
empirical intravenous antibiotics
All adults should initially receive empirical intravenous antibiotics based on local microbiology guidelines to cover the likely causative organisms, both aerobic and anaerobic. Clinicians should keep in mind differences between community-acquired and hospital-acquired pathogens. Once culture results from the pleural fluid are obtained, antibiotics may be tailored to the sensitivities of the grown culture.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
Empirical antibiotic treatment for hospital-acquired empyema should include antibiotics active against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa (e.g., vancomycin plus cefepime, and metronidazole; or vancomycin plus piperacillin/tazobactam) and keep in mind increasing resistance patterns. Clindamycin may be used as an alternative to metronidazole. Vancomycin plus meropenem may be indicated if there is a history or suspicion of extended spectrum beta-lactamase-producing organisms.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com As up to 25% of cases of hospital-acquired empyema are associated with MRSA, all patients (particularly postoperative and post-traumatic) should receive anti-staphylococcal cover.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
In general, empirical antibiotics with activity against atypical organisms are not necessary.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
Primary options
vancomycin: 500 mg intravenously every 6 hours; or 1000 mg intravenously every 12 hours
-- AND --
cefepime: 2 g intravenously every 8 hours
-- AND --
metronidazole: 15 mg/kg intravenously as a loading dose, followed by 7.5 mg/kg every 6 hours, maximum 4000 mg/day
or
clindamycin: 600 mg intravenously every 6-12 hours; or 900 mg intravenously every 8-12 hours
OR
vancomycin: 500 mg intravenously every 6 hours; or 1000 mg intravenously every 12 hours
and
piperacillin/tazobactam: 4.5 g intravenously every 6 hours
More piperacillin/tazobactamDose refers to 4 g piperacillin plus 0.5 g tazobactam.
OR
vancomycin: 500 mg intravenously every 6 hours; or 1000 mg intravenously every 12 hours
and
meropenem: 1 g intravenously every 8 hours
chest tube drainage
Treatment recommended for ALL patients in selected patient group
Urgent chest drain insertion is essential in all adults with empyema or complicated parapneumonic effusion.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
How to insert an intercostal (chest) drain using the Seldinger technique. Video demonstrates: how to identify a safe site for insertion; use of an introducer needle, guidewire, dilators, and intercostal drain; how to confirm drain position; and post-procedure care.
Chest drains should be inserted by competent personnel under imaging (ultrasound) guidance to reduce the risk of complications that include organ damage, haemorrhage, subcutaneous emphysema, and death.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com [40]Kesieme EB, Dongo A, Ezemba N, et al. Tube thoracostomy: complications and its management. Pulm Med. 2012;2012:256878. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195434 http://www.ncbi.nlm.nih.gov/pubmed/22028963?tool=bestpractice.com
There is no consensus on the optimal chest tube size for drainage, although it is likely that small-bore chest drains (10-14F) are as effective as large-bore drains (20-28F).[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com [41]Tattersall DJ, Traill ZC, Gleeson FV. Chest drains: does size matter? Clin Radiol. 2000 Jun;55(6):415-21. http://www.ncbi.nlm.nih.gov/pubmed/10873685?tool=bestpractice.com Small-bore drains have also been shown to be less painful for patients.[42]Hallifax RJ, Psallidas I, Rahman NM. Chest drain size: the debate continues. Curr Pulmonol Rep. 2017;6(1):26-9. https://link.springer.com/article/10.1007/s13665-017-0162-3 http://www.ncbi.nlm.nih.gov/pubmed/28344925?tool=bestpractice.com Regular flushing with saline is recommended for small-bore chest drains and if the chest drain becomes blocked.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
The chest drain should remain in place until the effusion has resolved and drainage has stopped.
supportive care
Treatment recommended for ALL patients in selected patient group
Antipyretics and analgesics should be administered as indicated. The authors make no recommendations for specific antipyretics and analgesics. Agents should be used in accordance with local protocols.
Good nursing care, ensuring maintenance of appropriate dietary intake with nutritional supplements if necessary, is paramount. Early mobilisation is also essential.
fluid resuscitation
Additional treatment recommended for SOME patients in selected patient group
Patients may be septic at presentation and require emergency fluid resuscitation and urgent intravenous antibiotics even before the diagnosis is established.
children (culture results pending)
empirical intravenous antibiotics
All children should initially receive empirical intravenous antibiotics based on local microbiology guidelines to cover the likely causative organisms.[26]Canadian Paediatric Society. Paediatric complicated pneumonia: diagnosis and management of empyema. Jan 2024 [internet publication]. https://cps.ca/en/documents/position/complicated-pneumonia-empyema
Antibiotics covering Streptococcus pneumoniae and Staphylococcus aureus[26]Canadian Paediatric Society. Paediatric complicated pneumonia: diagnosis and management of empyema. Jan 2024 [internet publication]. https://cps.ca/en/documents/position/complicated-pneumonia-empyema [27]Thoracic Society of Australia and New Zealand. Paediatric empyema thoracis: recommendations for management. 2011 [internet publication]. http://www.thoracic.org.au/journal-publishing/command/download_file/id/24/filename/PaediatricEmpyemaThoracisPositionStatementTSANZFINAL.pdf should be given.
Suitable choices include cefotaxime or ceftriaxone or ampicillin, depending on local guidelines or antibiograms.[26]Canadian Paediatric Society. Paediatric complicated pneumonia: diagnosis and management of empyema. Jan 2024 [internet publication]. https://cps.ca/en/documents/position/complicated-pneumonia-empyema The addition of vancomycin or linezolid is usually reserved for culture-proven or severe suspected MRSA infection.[26]Canadian Paediatric Society. Paediatric complicated pneumonia: diagnosis and management of empyema. Jan 2024 [internet publication]. https://cps.ca/en/documents/position/complicated-pneumonia-empyema
Once culture results from the pleural fluid are obtained, antibiotics may be tailored to the sensitivities of the grown culture.
Primary options
cefotaxime: body weight <50 kg: 150-180 mg/kg/day intravenously given in divided doses every 8 hours, maximum 8 g/day; body weight ≥50 kg: 1-2 g intravenously every 6-8 hours
OR
ceftriaxone: 50-100 mg/kg/day intravenously given in divided doses every 12-24 hours, maximum 4 g/day
OR
ampicillin: 150-400 mg/kg/day intravenously given in divided doses every 6 hours, maximum 12 g/day
OR
cefotaxime: body weight <50 kg: 150-180 mg/kg/day intravenously given in divided doses every 8 hours, maximum 8 g/day; body weight ≥50 kg: 1-2 g intravenously every 6-8 hours
or
ceftriaxone: 50-100 mg/kg/day intravenously given in divided doses every 12-24 hours, maximum 4 g/day
or
ampicillin: 150-400 mg/kg/day intravenously given in divided doses every 6 hours, maximum 12 g/day
-- AND --
vancomycin: 60 mg/kg/day intravenously given in divided doses every 6 hours
or
linezolid: children <12 years of age: 10 mg/kg (maximum 600 mg/dose) intravenously every 8 hours; children ≥12 years of age: 600 mg intravenously every 12 hours
chest tube drainage
Treatment recommended for ALL patients in selected patient group
Urgent chest drain insertion is essential in all children with empyema or complicated parapneumonic effusion.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com [50]Paraskakis E, Vergadi E, Chatzimichael A, et al. Current evidence for the management of paediatric parapneumonic effusions. Curr Med Res Opin. 2012 Jul;28(7):1179-92. http://www.ncbi.nlm.nih.gov/pubmed/22502916?tool=bestpractice.com
How to insert an intercostal (chest) drain using the Seldinger technique. Video demonstrates: how to identify a safe site for insertion; use of an introducer needle, guidewire, dilators, and intercostal drain; how to confirm drain position; and post-procedure care.
Chest drains should be inserted by competent personnel under imaging (ultrasound) guidance to reduce the risk of complications that include organ damage, haemorrhage, subcutaneous emphysema, and death.[40]Kesieme EB, Dongo A, Ezemba N, et al. Tube thoracostomy: complications and its management. Pulm Med. 2012;2012:256878. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195434 http://www.ncbi.nlm.nih.gov/pubmed/22028963?tool=bestpractice.com
Small drains should be used whenever possible to minimise patient discomfort.
The chest drain should remain in place until the effusion has resolved and drainage has stopped.
supportive care
Treatment recommended for ALL patients in selected patient group
Supplemental oxygen should be provided to children with SaO₂ <93%.[27]Thoracic Society of Australia and New Zealand. Paediatric empyema thoracis: recommendations for management. 2011 [internet publication]. http://www.thoracic.org.au/journal-publishing/command/download_file/id/24/filename/PaediatricEmpyemaThoracisPositionStatementTSANZFINAL.pdf
Antipyretics and analgesics should be administered as indicated. The authors make no recommendations for specific antipyretics and analgesics. Agents should be used in accordance with local protocols.
Good nursing care, ensuring maintenance of appropriate dietary intake with nutritional supplements if necessary, is paramount. Early mobilisation is also essential.
fluid resuscitation
Additional treatment recommended for SOME patients in selected patient group
Patients may be septic at presentation and require emergency fluid resuscitation and urgent intravenous antibiotics even before the diagnosis is established.
adults (culture results available)
antibiotics according to culture sensitivity
Once culture results from the pleural fluid are obtained, antibiotics should be tailored to the sensitivities of the grown culture.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
Antibiotics should not be discontinued following a negative culture, as pleural fluid cultures are negative in 40% of cases. In these patients, prolonged empirical antibiotic therapy may be required.[50]Paraskakis E, Vergadi E, Chatzimichael A, et al. Current evidence for the management of paediatric parapneumonic effusions. Curr Med Res Opin. 2012 Jul;28(7):1179-92. http://www.ncbi.nlm.nih.gov/pubmed/22502916?tool=bestpractice.com Even when anaerobic cultures are negative, continuation of empirical antibiotics covering both common community-acquired bacterial pathogens and anaerobic organisms should be considered, because anaerobes frequently infect empyemas and because anaerobes are not always cultured successfully.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
If the patient has responded to intravenous treatment, the source of infection has been controlled, the organism is susceptible to oral antibiotics, and the patient’s oral intake is acceptable, then a transition to oral treatment can be made.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
Although the optimum duration of treatment is unknown, antibiotic therapy is generally continued for at least 3 weeks. The Working Group of the American Association for Thoracic Surgery recommends a minimum of 2 weeks from the time of drainage and settling of the fever, and states that clinical response, source control, and pathogen should all play a role in treatment decisions.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
Inflammatory markers (WBC count and CRP) are useful as guides to the required duration of antibiotic treatment.
chest tube drainage
Treatment recommended for ALL patients in selected patient group
Urgent chest drain insertion is essential in all adults with empyema or complicated parapneumonic effusion.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
How to insert an intercostal (chest) drain using the Seldinger technique. Video demonstrates: how to identify a safe site for insertion; use of an introducer needle, guidewire, dilators, and intercostal drain; how to confirm drain position; and post-procedure care.
Chest drains should be inserted by competent personnel under imaging (ultrasound) guidance to reduce the risk of complications that include organ damage, haemorrhage, subcutaneous emphysema, and death.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com [40]Kesieme EB, Dongo A, Ezemba N, et al. Tube thoracostomy: complications and its management. Pulm Med. 2012;2012:256878. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195434 http://www.ncbi.nlm.nih.gov/pubmed/22028963?tool=bestpractice.com
There is no consensus on the optimal chest tube size for drainage, although it is likely that small-bore chest drains (10-14F) are as effective as large-bore drains (20-28F).[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com [41]Tattersall DJ, Traill ZC, Gleeson FV. Chest drains: does size matter? Clin Radiol. 2000 Jun;55(6):415-21. http://www.ncbi.nlm.nih.gov/pubmed/10873685?tool=bestpractice.com Small-bore drains have also been shown to be less painful for patients.[42]Hallifax RJ, Psallidas I, Rahman NM. Chest drain size: the debate continues. Curr Pulmonol Rep. 2017;6(1):26-9. https://link.springer.com/article/10.1007/s13665-017-0162-3 http://www.ncbi.nlm.nih.gov/pubmed/28344925?tool=bestpractice.com
Regular flushing with saline is recommended for small-bore chest drains and if the chest drain becomes blocked.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
The chest drain should remain in place until the effusion has resolved and drainage has stopped.
supportive care
Treatment recommended for ALL patients in selected patient group
Intravenous fluid treatment for sepsis should be continued as required.
Antipyretics and analgesics should be administered as indicated. The authors make no recommendations for specific antipyretics and analgesics. Agents should be used in accordance with local protocols.
Good nursing care, ensuring maintenance of appropriate dietary intake with nutritional supplements if necessary, is paramount. Early mobilisation is also essential.
intrapleural enzyme therapy
Additional treatment recommended for SOME patients in selected patient group
Intrapleural enzyme therapy consists of a combination of tissue plasminogen activator (t-PA) and dornase alfa (deoxyribonuclease [DNAse]). The medicines are instilled into the chest tube and allowed to dwell for 1 hour.
Should be considered in haemodynamically unstable and older patients, patients who are not candidates for surgery (e.g., due to comorbidity), in those with a large effusion not relieved with chest tube drainage and causing respiratory compromise, and in institutions where video-assisted thoracoscopic surgery is not available.[45]Altmann ES, Crossingham I, Wilson S, et al. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD002312. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002312.pub4/full http://www.ncbi.nlm.nih.gov/pubmed/31684683?tool=bestpractice.com [46]Bouros D, Tzouvelekis A, Antoniou KM, et al. Intrapleural fibrinolytic therapy for pleural infection. Pulm Pharmacol Ther. 2007;20(6):616-26. http://www.ncbi.nlm.nih.gov/pubmed/17049447?tool=bestpractice.com American Association for Thoracic Surgery guidelines do not support routine use of intrapleural fibrinolytics for complicated pleural effusions and early empyemas.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
Some experts support routine consideration of intrapleural enzyme therapy for either initial or subsequent treatment of empyema, but only following multidisciplinary risk-benefit discussion and depending on local expertise and the availability of minimally invasive surgical services.[43]Chaddha U, Agrawal A, Feller-Kopman D, et al. Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: a consensus statement. Lancet Respir Med. 2021 Sep;9(9):1050-64. http://www.ncbi.nlm.nih.gov/pubmed/33545086?tool=bestpractice.com
Most experts recommend use of a combination of a fibrinolytic and dornase alfa in place of monotherapy.
Primary options
alteplase: 10 mg intrapleurally twice daily for 3 days
and
dornase alfa: 5 mg intrapleurally twice daily for 3 days
video-assisted thoracoscopic surgery (VATS)
Patients who do not respond to antibiotics and tube thoracostomy (chest drain insertion) should be referred to a thoracic surgeon for consideration of surgical intervention. Failure to respond is a clinical decision based on ongoing fever, failure of pleural fluid drainage, and persistently raised inflammatory markers. Approximately 30% of patients will require surgery.[23]Maskell NA, Davies CW, Nunn AJ, et al. UK controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005 Mar 3;352(9):865-74. http://www.nejm.org/doi/full/10.1056/NEJMoa042473#t=article http://www.ncbi.nlm.nih.gov/pubmed/15745977?tool=bestpractice.com
The optimal time at which to refer for surgery is unclear. Some authorities advocate immediate surgery for all patients, but this is debated. The American Association for Thoracic Surgery recommends VATS as the first-line approach in all patients with stage 2 acute empyema.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com However, some experts support a trial of combination therapy with a fibrinolytic agent and dornase alfa before considering surgery for patients with stage 2 empyema, or for patients with stage 3 empyema awaiting a surgical consultation.[43]Chaddha U, Agrawal A, Feller-Kopman D, et al. Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: a consensus statement. Lancet Respir Med. 2021 Sep;9(9):1050-64. http://www.ncbi.nlm.nih.gov/pubmed/33545086?tool=bestpractice.com
The first-line surgical option is VATS, as it is a less invasive procedure, with less post-operative pain, shorter hospital length of stay, less blood loss, less respiratory compromise, fewer post-operative complications, and lower cost compared with open thoracotomy.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
In patients with ineffective effusion drainage and persistent sepsis who cannot tolerate general anaesthesia, re-evaluation with re-imaging of the thorax and, after discussion with a thoracic surgeon, placement of another image-guided small-bore catheter or a larger bore chest tube, or intrapleural fibrinolytic may be considered.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
supportive care + continued antibiotics
Treatment recommended for ALL patients in selected patient group
Intravenous fluid treatment for sepsis should be continued as required.
Antipyretics and analgesics should be administered as indicated. The authors make no recommendations for specific antipyretics and analgesics. Agents should be used in accordance with local protocols.
Good nursing care, ensuring maintenance of appropriate dietary intake with nutritional supplements if necessary, is paramount. Early mobilisation is also essential.
Antibiotics should be continued. If the patient has responded to intravenous treatment, the source of infection has been controlled, the organism is susceptible to oral antibiotics, and the patient’s oral intake is acceptable, then a transition to oral treatment can be made.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
Although the optimum duration of treatment is unknown, antibiotic therapy is generally continued for at least 3 weeks. The Working Group of the American Association for Thoracic Surgery recommends a minimum of 2 weeks from the time of drainage and settling of the fever, and states that clinical response, source control, and pathogen should all play a role in treatment decisions.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com Inflammatory markers (WBC count and CRP) are useful as guides to the required duration of antibiotic treatment.
intrapleural enzyme therapy
Intrapleural enzyme therapy consists of a combination of alteplase (recombinant tissue plasminogen activator [t-PA]) and dornase alfa (deoxyribonuclease [DNAse]). The medicines are instilled into the chest tube and allowed to dwell for 1 hour.
May be indicated for the decompression of multiloculated and tube drainage-resistant pleural effusions that are responsible for dyspnoea or respiratory failure if a thoracic surgeon identifies that surgery is not immediately possible (e.g., patient co-morbidity or other clinical or logistical reasons).[44]Janda S, Swiston J. Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas: a systematic review and meta-analysis. Chest. 2012 Aug;142(2):401-11. http://www.ncbi.nlm.nih.gov/pubmed/22459772?tool=bestpractice.com Some experts support routine consideration of intrapleural enzyme therapy for either initial or subsequent treatment of empyema, but only following multidisciplinary risk-benefit discussion and depending on local expertise and the availability of minimally invasive surgical services.[43]Chaddha U, Agrawal A, Feller-Kopman D, et al. Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: a consensus statement. Lancet Respir Med. 2021 Sep;9(9):1050-64. http://www.ncbi.nlm.nih.gov/pubmed/33545086?tool=bestpractice.com
Intrapleural therapy should be considered in haemodynamically unstable and older patients, patients who are not candidates for surgery (e.g., due to comorbidity), in those with a large effusion not relieved with chest tube drainage and causing respiratory compromise, and in institutions where VATS is not available.[45]Altmann ES, Crossingham I, Wilson S, et al. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD002312. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002312.pub4/full http://www.ncbi.nlm.nih.gov/pubmed/31684683?tool=bestpractice.com [46]Bouros D, Tzouvelekis A, Antoniou KM, et al. Intrapleural fibrinolytic therapy for pleural infection. Pulm Pharmacol Ther. 2007;20(6):616-26. http://www.ncbi.nlm.nih.gov/pubmed/17049447?tool=bestpractice.com American Association for Thoracic Surgery guidelines do not support routine use of intrapleural fibrinolytics for complicated pleural effusions and early empyemas.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
Most experts recommend use of a combination of a fibrinolytic and dornase alfa in place of monotherapy.
Primary options
alteplase: 10 mg intrapleurally twice daily for 3 days
and
dornase alfa: 5 mg intrapleurally twice daily for 3 days
supportive care + continued antibiotics
Treatment recommended for ALL patients in selected patient group
Intravenous fluid treatment for sepsis should be continued as required.
Antipyretics and analgesics should be administered as indicated. The authors make no recommendations for specific antipyretics and analgesics. Agents should be used in accordance with local protocols.
Good nursing care, ensuring maintenance of appropriate dietary intake with nutritional supplements if necessary, is paramount. Early mobilisation is also essential.
Antibiotics should be continued. If the patient has responded to intravenous treatment, the source of infection has been controlled, the organism is susceptible to oral antibiotics, and the patient’s oral intake is acceptable, then a transition to oral treatment can be made.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
Although the optimum duration of treatment is unknown, antibiotic therapy is generally continued for at least 3 weeks. The Working Group of the American Association for Thoracic Surgery recommends a minimum of 2 weeks from the time of drainage and settling of the fever, and states that clinical response, source control, and pathogen should all play a role in treatment decisions.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com Inflammatory markers (WBC count and CRP) are useful as guides to the required duration of antibiotic treatment.
mini-thoracotomy, decortication, or open thoracic drainage
If there is inadequate resolution of the empyema following video-assisted thoracoscopic surgery or intrapleural enzyme therapy, further surgical options should be discussed with a thoracic surgeon.
These include mini-thoracotomy, decortication (a major thoracic operation involving the evacuation of pus and debris from the pleural space and removal of fibrous tissue from the visceral and parietal pleura), and open thoracic drainage.
Local anaesthetic thoracoscopy may be useful for the treatment of empyema, allowing division of septations and adhesions and facilitating accurate tube placement and drainage, but is not routinely used, as large prospective randomised trials are still needed to elucidate its role for empyema.
A thoracic surgeon should be involved in assessment of the patient, even for anaesthesia. Less radical surgical interventions, depending on surgical expertise and access, such as rib resection and placement of a large-bore drain, may be considered in unstable patients and can be performed in some cases with epidural or local anaesthesia.
supportive care + continued antibiotics
Treatment recommended for ALL patients in selected patient group
Intravenous fluid treatment for sepsis should be continued as required.
Antipyretics and analgesics should be administered as indicated. The authors make no recommendations for specific antipyretics and analgesics. Agents should be used in accordance with local protocols.
Good nursing care, ensuring maintenance of appropriate dietary intake with nutritional supplements if necessary, is paramount. Early mobilisation is also essential.
Antibiotics should be continued. If the patient has responded to intravenous treatment, the source of infection has been controlled, the organism is susceptible to oral antibiotics, and the patient’s oral intake is acceptable, then a transition to oral treatment can be made.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
Although the optimum duration of treatment is unknown, antibiotic therapy is generally continued for at least 3 weeks. The Working Group of the American Association for Thoracic Surgery recommends a minimum of 2 weeks from the time of drainage and settling of the fever, and states that clinical response, source control, and pathogen should all play a role in treatment decisions.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com Inflammatory markers (WBC count and CRP) are useful as guides to the required duration of antibiotic treatment.
indwelling pleural catheter
May rarely have a role in maintaining drainage of a chronically infected pleural space that is not readily treated in other ways such as surgery.
supportive care + continued antibiotics
Treatment recommended for ALL patients in selected patient group
Intravenous fluid treatment for sepsis should be continued as required.
Antipyretics and analgesics should be administered as indicated. The authors make no recommendations for specific antipyretics and analgesics. Agents should be used in accordance with local protocols.
Good nursing care, ensuring maintenance of appropriate dietary intake with nutritional supplements if necessary, is paramount. Early mobilisation is also essential.
Antibiotics should be continued. If the patient has responded to intravenous treatment, the source of infection has been controlled, the organism is susceptible to oral antibiotics, and the patient’s oral intake is acceptable, then a transition to oral treatment can be made.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
Although the optimum duration of treatment is unknown, antibiotic therapy is generally continued for at least 3 weeks. The Working Group of the American Association for Thoracic Surgery recommends a minimum of 2 weeks from the time of drainage and settling of the fever, and states that clinical response, source control, and pathogen should all play a role in treatment decisions.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com Inflammatory markers (WBC count and CRP) are useful as guides to the required duration of antibiotic treatment.
children (culture results available)
antibiotics according to culture sensitivity
Once culture results from the pleural fluid are obtained, antibiotics may be tailored to the sensitivities of the grown culture.
Antibiotics should not be discontinued following a negative culture as pleural fluid cultures are negative in 40% of cases. In these patients, prolonged empirical antibiotic therapy may be required.[50]Paraskakis E, Vergadi E, Chatzimichael A, et al. Current evidence for the management of paediatric parapneumonic effusions. Curr Med Res Opin. 2012 Jul;28(7):1179-92. http://www.ncbi.nlm.nih.gov/pubmed/22502916?tool=bestpractice.com
When drainage has been completed, and the patient is clinically improving and off oxygen, the route of antibiotic administration may be changed to oral.[26]Canadian Paediatric Society. Paediatric complicated pneumonia: diagnosis and management of empyema. Jan 2024 [internet publication]. https://cps.ca/en/documents/position/complicated-pneumonia-empyema
Inflammatory markers (WBC count and CRP) are useful as guides to the required duration of antibiotic treatment.
chest tube drainage
Treatment recommended for ALL patients in selected patient group
Urgent chest drain insertion is essential in all children with empyema or complicated parapneumonic effusion.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com [50]Paraskakis E, Vergadi E, Chatzimichael A, et al. Current evidence for the management of paediatric parapneumonic effusions. Curr Med Res Opin. 2012 Jul;28(7):1179-92. http://www.ncbi.nlm.nih.gov/pubmed/22502916?tool=bestpractice.com
How to insert an intercostal (chest) drain using the Seldinger technique. Video demonstrates: how to identify a safe site for insertion; use of an introducer needle, guidewire, dilators, and intercostal drain; how to confirm drain position; and post-procedure care.
Chest drains should be inserted by competent personnel under imaging (ultrasound) guidance to reduce the risk of complications that include organ damage, haemorrhage, subcutaneous emphysema, and death.[40]Kesieme EB, Dongo A, Ezemba N, et al. Tube thoracostomy: complications and its management. Pulm Med. 2012;2012:256878. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195434 http://www.ncbi.nlm.nih.gov/pubmed/22028963?tool=bestpractice.com
Small drains should be used whenever possible to minimise patient discomfort.
The chest drain should remain in place until the effusion has resolved and drainage has stopped.
supportive care
Treatment recommended for ALL patients in selected patient group
Supplemental oxygen should be provided to children with SaO₂ <93%.[27]Thoracic Society of Australia and New Zealand. Paediatric empyema thoracis: recommendations for management. 2011 [internet publication]. http://www.thoracic.org.au/journal-publishing/command/download_file/id/24/filename/PaediatricEmpyemaThoracisPositionStatementTSANZFINAL.pdf
Intravenous fluid treatment for sepsis should be continued as required.
Antipyretics and analgesics should be administered as indicated. The authors make no recommendations for specific antipyretics and analgesics. Agents should be used in accordance with local protocols.
Good nursing care, ensuring maintenance of appropriate dietary intake with nutritional supplements if necessary, is paramount. Early mobilisation is also essential.
intrapleural enzyme therapy
Most experts recommend use of a combination of a fibrinolytic and dornase alfa (deoxyribonuclease [DNAse]) in place of monotherapy.[43]Chaddha U, Agrawal A, Feller-Kopman D, et al. Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: a consensus statement. Lancet Respir Med. 2021 Sep;9(9):1050-64. http://www.ncbi.nlm.nih.gov/pubmed/33545086?tool=bestpractice.com The medicines are instilled into the chest tube and allowed to dwell for 1 hour.
Should be considered if antibiotics and chest tube drainage do not result in adequate resolution of the empyema.
Urokinase is the only fibrinolytic drug that has been studied and recommended in children.[51]Thomson AH, Hull J, Kumar MR, et al. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax. 2002 Apr;57(4):343-7. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1746300/pdf/v057p00343.pdf http://www.ncbi.nlm.nih.gov/pubmed/11923554?tool=bestpractice.com [52]Marhuenda C, Barceló C, Fuentes I, et al. Urokinase versus VATS for treatment of empyema: a randomized multicenter clinical trial. Pediatrics. 2014 Nov;134(5):e1301-7. https://pediatrics.aappublications.org/content/134/5/e1301.long http://www.ncbi.nlm.nih.gov/pubmed/25349313?tool=bestpractice.com It has been shown to shorten hospital stay and a small study also found chest drainage plus urokinase instillation to be as effective as video-assisted thoracoscopic surgery in the first-line treatment of septated parapneumonic effusion in children.[51]Thomson AH, Hull J, Kumar MR, et al. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax. 2002 Apr;57(4):343-7. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1746300/pdf/v057p00343.pdf http://www.ncbi.nlm.nih.gov/pubmed/11923554?tool=bestpractice.com [52]Marhuenda C, Barceló C, Fuentes I, et al. Urokinase versus VATS for treatment of empyema: a randomized multicenter clinical trial. Pediatrics. 2014 Nov;134(5):e1301-7. https://pediatrics.aappublications.org/content/134/5/e1301.long http://www.ncbi.nlm.nih.gov/pubmed/25349313?tool=bestpractice.com If urokinase is not available, alteplase (recombinant tissue plasminogen activator) is a suitable alternative option.[26]Canadian Paediatric Society. Paediatric complicated pneumonia: diagnosis and management of empyema. Jan 2024 [internet publication]. https://cps.ca/en/documents/position/complicated-pneumonia-empyema [27]Thoracic Society of Australia and New Zealand. Paediatric empyema thoracis: recommendations for management. 2011 [internet publication]. http://www.thoracic.org.au/journal-publishing/command/download_file/id/24/filename/PaediatricEmpyemaThoracisPositionStatementTSANZFINAL.pdf Although it has been successfully evaluated in paediatric patients with empyema, some data show no difference in length of hospital stay between chest tube drainage and use of intrapleural tissue plasminogen activator.[53]St Peter SD, Tsao K, Harrison C, et al. Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial. J Pediatr Surg. 2009 Jan;44(1):106-11;discussion 111. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086274 http://www.ncbi.nlm.nih.gov/pubmed/19159726?tool=bestpractice.com
Primary options
urokinase: consult specialist for guidance on intrapleural dose
and
dornase alfa: 5 mg intrapleurally twice daily for 3 days
Secondary options
alteplase: 10 mg intrapleurally twice daily for 3 days
and
dornase alfa: 5 mg intrapleurally twice daily for 3 days
supportive care + continued antibiotics
Treatment recommended for ALL patients in selected patient group
Supplemental oxygen should be provided to children with SaO₂ <93%.[27]Thoracic Society of Australia and New Zealand. Paediatric empyema thoracis: recommendations for management. 2011 [internet publication]. http://www.thoracic.org.au/journal-publishing/command/download_file/id/24/filename/PaediatricEmpyemaThoracisPositionStatementTSANZFINAL.pdf
Intravenous fluid treatment for sepsis should be continued as required.
Antipyretics and analgesics should be administered as indicated. The authors make no recommendations for specific antipyretics and analgesics. Agents should be used in accordance with local protocols.
Good nursing care, ensuring maintenance of appropriate dietary intake with nutritional supplements if necessary, is paramount. Early mobilisation is also essential.
Antibiotics should be continued. When drainage has been completed, and the patient is clinically improving and off oxygen, the route of antibiotic administration may be changed to oral.[26]Canadian Paediatric Society. Paediatric complicated pneumonia: diagnosis and management of empyema. Jan 2024 [internet publication]. https://cps.ca/en/documents/position/complicated-pneumonia-empyema Inflammatory markers (WBC count and CRP) are useful as guides to the required duration of antibiotic treatment.
video-assisted thoracoscopic surgery (VATS)
Children who do not respond to antibiotics and tube thoracostomy (chest drain insertion) should be referred to a thoracic surgeon for consideration of VATS.[27]Thoracic Society of Australia and New Zealand. Paediatric empyema thoracis: recommendations for management. 2011 [internet publication]. http://www.thoracic.org.au/journal-publishing/command/download_file/id/24/filename/PaediatricEmpyemaThoracisPositionStatementTSANZFINAL.pdf [50]Paraskakis E, Vergadi E, Chatzimichael A, et al. Current evidence for the management of paediatric parapneumonic effusions. Curr Med Res Opin. 2012 Jul;28(7):1179-92. http://www.ncbi.nlm.nih.gov/pubmed/22502916?tool=bestpractice.com
Failure to respond is a clinical judgement based on ongoing fever, failure of pleural fluid drainage, and persistently raised inflammatory markers.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com
supportive care + continued antibiotics
Treatment recommended for ALL patients in selected patient group
Supplemental oxygen should be provided to children with SaO₂ <93%.[27]Thoracic Society of Australia and New Zealand. Paediatric empyema thoracis: recommendations for management. 2011 [internet publication]. http://www.thoracic.org.au/journal-publishing/command/download_file/id/24/filename/PaediatricEmpyemaThoracisPositionStatementTSANZFINAL.pdf
Intravenous fluid treatment for sepsis should be continued as required.
Antipyretics and analgesics should be administered as indicated. The authors make no recommendations for specific antipyretics and analgesics. Agents should be used in accordance with local protocols.
Good nursing care, ensuring maintenance of appropriate dietary intake with nutritional supplements if necessary, is paramount. Early mobilisation is also essential.
Antibiotics should be continued. When drainage has been completed, and the patient is clinically improving and off oxygen, the route of antibiotic administration may be changed to oral.[26]Canadian Paediatric Society. Paediatric complicated pneumonia: diagnosis and management of empyema. Jan 2024 [internet publication]. https://cps.ca/en/documents/position/complicated-pneumonia-empyema Inflammatory markers (WBC count and CRP) are useful as guides to the required duration of antibiotic treatment.
mini-thoracotomy, decortication, or open thoracic drainage
If video-assisted thoracoscopic surgery (VATS) is not available or does not result in adequate resolution of the empyema, further surgical options should be discussed with a thoracic surgeon. VATS debridement is preferred over open thoracotomy.[8]Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. https://www.jtcvs.org/article/S0022-5223(17)30152-6/fulltext http://www.ncbi.nlm.nih.gov/pubmed/28274565?tool=bestpractice.com Mini-thoracotomy is the first choice of other surgical procedures.
Organised empyemas in symptomatic children may require open surgery or decortication, a major thoracic operation involving the evacuation of pus and debris from the pleural space and removal of fibrous tissue from the visceral and parietal pleura.[50]Paraskakis E, Vergadi E, Chatzimichael A, et al. Current evidence for the management of paediatric parapneumonic effusions. Curr Med Res Opin. 2012 Jul;28(7):1179-92. http://www.ncbi.nlm.nih.gov/pubmed/22502916?tool=bestpractice.com
supportive care + continued antibiotics
Treatment recommended for ALL patients in selected patient group
Supplemental oxygen should be provided to children with SaO₂ <93%.[27]Thoracic Society of Australia and New Zealand. Paediatric empyema thoracis: recommendations for management. 2011 [internet publication]. http://www.thoracic.org.au/journal-publishing/command/download_file/id/24/filename/PaediatricEmpyemaThoracisPositionStatementTSANZFINAL.pdf
Intravenous fluid treatment for sepsis should be continued as required.
Antipyretics and analgesics should be administered as indicated. The authors make no recommendations for specific antipyretics and analgesics. Agents should be used in accordance with local protocols.
Good nursing care, ensuring maintenance of appropriate dietary intake with nutritional supplements if necessary, is paramount. Early mobilisation is also essential.
Antibiotics should be continued. When drainage has been completed, and the patient is clinically improving and off oxygen, the route of antibiotic administration may be changed to oral.[26]Canadian Paediatric Society. Paediatric complicated pneumonia: diagnosis and management of empyema. Jan 2024 [internet publication]. https://cps.ca/en/documents/position/complicated-pneumonia-empyema Inflammatory markers (WBC count and CRP) are useful as guides to the required duration of antibiotic treatment.
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer